Article
Is screening for factor V Leiden and prothrombin G20210A mutations in renal transplantation worthwhile? Results of a large single-center U.K. study.
Transplantation - 15 Aug 2003
Pherwani Arun D, Winter Paul C, McNamee Peter T, Patterson Chris C, Hill Claire M, Connolly John K, Maxwell A Peter
Abstract excerpt
This single center study is the largest series of renal transplant recipients and donors screened for the commonest prothrombotic genotypes. A total of 562 transplant recipients and 457 kidney donors were genotyped for the factor V Leiden and prothrombin G20210A mutations. The prevalence of heterozygous factor V Leiden was 3.4% and 2.6% and prothrombin G20210A was 2.0% and 1.1% in recipients and donors,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.